The aim of this study was to evaluate whether pulmonary diffusing capacity is impaired in patients with fibromyalgia (FM) as it is in those with other diseases characterised by autonomic nerve system (ANS) dysfunction such as type 1 diabetes.

Impaired lung transfer factor in fibromyalgia syndrome / M. Rizzi, F. Atzeni, A. Airoldi, I.F. Masala, F. Frassanito, F. Salaffi, C. Macaluso, P. Sarzi-Puttini. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 34:2 Suppl. 96(2016), pp. 114-119.

Impaired lung transfer factor in fibromyalgia syndrome

P. Sarzi-Puttini
Ultimo
2016

Abstract

The aim of this study was to evaluate whether pulmonary diffusing capacity is impaired in patients with fibromyalgia (FM) as it is in those with other diseases characterised by autonomic nerve system (ANS) dysfunction such as type 1 diabetes.
Blood Pressure; Catecholamines; Electrocardiography; Female; Humans; Lung; Lung Volume Measurements; Middle Aged; Plethysmography; Proportional Hazards Models; Severity of Illness Index; Fibromyalgia; Sympathetic Nervous System
Settore MED/16 - Reumatologia
2016
https://www.clinexprheumatol.org/abstract.asp?a=10165
Article (author)
File in questo prodotto:
File Dimensione Formato  
Impaired lung transfer factor in fibromyalgia syndrome.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 427.47 kB
Formato Adobe PDF
427.47 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/640579
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact